Upcoming Events
Valuation of Emerging Technologies
July 13th, 2017
Einhoven, Netherlands
Calculating Damages Resulting From Patent Infringement
July 14th, 2017
Einhoven, Netherlands
Negotiating Licensing Agreements for Maximum Returns
July 14th, 2017
Einhoven, Netherlands
Enhanced Negotiating Strategies
August 17th, 2017
New York, NY
Enhanced Negotiating Strategies
August 24th, 2017
Silicon Valley, CA
Valuation of Emerging Companies
August 30th, 2017
Silicon Valley, CA
Advanced Patent Valuation
February 15th, 2018
Advanced Patent Valuation
February 15th, 2018

Valuation of Emerging Technologies

About the Course:

The overwhelming value of most early-stage companies resides in their intellectual assets. However, senior managers of such companies usually have no idea how to value their inventions. This is unfortunate as the inability to value intangible assets puts companies at a severe disadvantage when trying to monetize their discoveries through capital raises, licensing, joint-ventures or sales.

Inventors, investors, patentees, licensors and licensees must be able to articulate the value of their patents and emerging technologies. Otherwise, they will never receive the valuations that they deserve.

This seminar provides an in-depth review of more than 20 Valuation Methodologies such as:

  • Cost Method
  • Market Method
  • Income Method
  • Decision Trees
  • Competitive Advantage Valuation
  • 25% Rule
  • The Monte Carlo Method
  • Real Options Method
  • Binomial Method
  • Probability Weighted Expected Return Method
  • Relief from Royalty Method
  • Excess Earnings Method
  • Markov Chains
  • Bayesian Analysis
  • Probabalistic Methodologies
Case studies / exercises relating to the following are among those reviewed in the course:
  • Acquisition Comparables
  • Stock Price Indication Methods
  • Venture Funding Comparables
  • Bayesian Analysis
  • Probabalistic Methodologies
  • Cross-Licensing
This seminar will introduce you to the Patent Valuation Gauntlet (PVG). In deriving the value of a patent, PVG takes into account commercial value, assertion value, blocking value, cross-licensing value, reputational value as well as patent invalidity risks and design around risks. The PVG worksheet contains more than 500 issues that should be considered when calculating the value of a patent. Additional Valuation Considerations to be Discussed Include:
  • Citation Analysis
  • Enforceability
  • Current Impact
  • Claim Scope Breadth
  • Technology Strength
  • Validity Confidence
  • Research Intensity
  • Litigation Avoidance
  • Science Strength
  • Partnering Licensing Potential
  • Innovation Cycle Time
  • Technology Cogency

Excel sheets with the more than 40 valuation methodologies are included with your registration.

Bonus Book: Attendees of live courses receive a handbook which sells for $295 for FREE. This Valuation of Emerging Technologies Handbook includes over 300 slides, articles and presentations which focus on all aspects of valuing early-stage technologies. Over 40 valuation methodologies are illustrated as well as dozens of patent valuation metrics.

*This course is also offered on a custom basis. The content can be customized to meet your company's specific needs and can also be delivered exclusively to your employees at your offices.

For further information, please contact Neomi Barazani at 609-919-1895 ext. 100 or info@bdacademy.com.

About the Instructor:

David Wanetick, Managing Director, IncreMental Advantage, LLC

IncreMental Advantage is an internationally recognized valuation firm with an expertise in valuing intangible assets and emerging technologies. Clients include companies ranging from start-ups to Fortune 100 companies, technology transfer offices, incubators, venture capital firms and private equity players.

David developed both the Certified Patent Valuation Analyst and the Certified Emerging Company Analyst designations.

David is the author of four books that have achieved world-wide acclaim, including the only two books that unveil Industry Analysis. His most recent book is entitled Business Model Validation.

He has been a guest on CNBC, Bloomberg and CNNfn and has been quoted in the Wall Street Journal, Barrons, Investor's Business Daily, Boards & Directors, and many other newspapers, blogs and magazines throughout the United States. His articles on Valuing Patents and Early-Stage Technologies and Negotiating Licensing Agreements have been published in Intellectual Asset Management, CEO Magazine, Licensing Journal, Willamette Insights, Valuation Strategies, IP Frontline, Technology Transfer Tactics, Inventor's Digest, The Canadian Institute of Chartered Business Valuators, and others.

David speaks about early-stage company valuation and IP valuation before many organizations and corporations. He has lectured all over the United States, Canada, The United Kingdom, The Netherlands, Belgium, Germany, Spain, Dubai, China, Denmark, Thailand, Singapore, Kuwait, Malaysia, Hong Kong, India and Israel.

Course Length:

Approx. 8 hours

Course Schedule:

Eindhoven, Netherlands – July 13, 2017
Location: NLO
Kennedyplein 236
5611 ZT Eindhoven
Time: 9:00 AM – 5:00 PM

Webinars: This rate is for one participant. Distribution of login information is prohibited. Site licenses for up to five participants are available for $3,295. To arrange a site license, please contact Neomi Barazani at 609-919-1895 ext. 100 or info@bdacademy.com.

Seating is Limited to 15 per session
Register online or by contacting
Registration / Membership Coordinator,
at 609-919-1895 ext. 100 or info@bdacademy.com

Requests to cancel your registration must be made in writing one month before the date of the seminar. Your refund will reflect a $95 processing fee. No refunds will be granted within one month of the course for which you are enrolled. You may send a substitute for an additional $55 processing fee.

Tuition - $1,095.00

Copyright © 2017 The Business Development Academy | All Rights Reserved

Privacy Statement: The Business Development Academy (BDA) does not, share, trade, sell, publish or otherwise distribute its membership list, in whole or part, with any other company or individual, at any time.